Clinical trials in amyotrophic lateral sclerosis: The tenuous past and the promising future

被引：9

作者：

Choudry, RB ^{[1
]}

Cudkowicz, ME ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Neurol Clin Trials Unit, Dept Neurol, Boston, MA 02114 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 45卷 / 12期

关键词：

amyotrophic lateral sclerosis; clinical trials; drug trials;

D O I：

10.1177/0091270005282631

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The post decade of research in amyotrophic lateral sclerosis has contributed to a greater understanding of the disease-process, the development of relevant animal models, and the identification of several therapeutic approaches that may delay disease progression. Completed and ongoing clinical trials and the process of selecting drugs for clinical trials are presented.

引用

页码：1334 / 1344

页数：11

共 50 条

[41] Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present
Pagani, Mario Rafael
Gonzalez, Laura Elisabeth
Uchitel, Osvaldo Daniel
NEUROLOGY RESEARCH INTERNATIONAL, 2011, 2011
[42] THERAPEUTIC TRIALS IN AMYOTROPHIC-LATERAL-SCLEROSIS
POTES, E
CHERRY, S
HOFFMAN, PM
MAYER, RF
MUSCLE & NERVE, 1986, 9 (05) : 106 - 106
[43] Amyotrophic lateral sclerosis and lovastatin: a promising treatment perspective
Nadeem, Zain Ali
Ahmed, Sophia
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2025,
[44] Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies
Wei, Yuqing
Zhong, Sheng
Yang, Huajing
Wang, Xueqing
Lv, Bingbing
Bian, Yaoyao
Pei, Yuqiong
Xu, Chunlei
Zhao, Qun
Wu, Yulan
Luo, Daying
Wang, Fan
Sun, Haopeng
Chen, Yao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 272
[45] Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis
Sever, Belgin
Ciftci, Halilibrahim
DeMirci, Hasan
Sever, Hilal
Ocak, Firdevs
Yulug, Burak
Tateishi, Hiroshi
Tateishi, Takahisa
Otsuka, Masami
Fujita, Mikako
Basak, Ayse Nazli
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
[46] Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data
Han, Moon
Raymond, Jaime
Larson, Theodore C.
Mehta, Paul
Horton, D. Kevin
JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2024,
[47] Attrition and discontinuation in amyotrophic lateral sclerosis clinical trials: a meta-analysis
van Eijk, Ruben P. A.
van Loon, Floris T.
van Unnik, Jordi W. J.
Weemering, Daphne N.
Seitidis, Georgios
Mavridis, Dimitris
van den Berg, Leonard H.
Nikolakopoulos, Stavros
JOURNAL OF NEUROLOGY, 2025, 272 (01)
[48] SURVIVAL EFFECT OF RILUZOLE EXPOSURE IN A METADATABASE OF AMYOTROPHIC LATERAL SCLEROSIS CLINICAL TRIALS
Wang, Leo
Ney, John
MUSCLE & NERVE, 2014, 50 (04) : 654 - 654
[49] Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials
van Eijk, Ruben P. A.
Eijkemans, Marinus J. C.
Ferguson, Toby A.
Nikolakopoulos, Stavros
Veldink, Jan H.
van den Berg, Leonard H.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (02): : 156 - 161
[50] Enhancing clinical trials in neurodegenerative disorders: lessons from amyotrophic lateral sclerosis
Gladman, Matthew
Cudkowicz, Merit
Zinman, Lorne
CURRENT OPINION IN NEUROLOGY, 2012, 25 (06) : 735 - 742

← 1 2 3 4 5 →